PROXERA PSOMED 40

· ICIM International S.r.l.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PROXERA PSOMED 40, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis [NA]

See pricing